233 related articles for article (PubMed ID: 1874188)
1. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
Moon LY; Wakley GK; Turner RT
Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
[TBL] [Abstract][Full Text] [Related]
2. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
[TBL] [Abstract][Full Text] [Related]
3. Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia.
Sibonga JD; Dobnig H; Harden RM; Turner RT
Endocrinology; 1998 Sep; 139(9):3736-42. PubMed ID: 9724025
[TBL] [Abstract][Full Text] [Related]
4. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
5. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone.
Sibonga JD; Bell NH; Turner RT
J Bone Miner Res; 1998 May; 13(5):863-70. PubMed ID: 9610751
[TBL] [Abstract][Full Text] [Related]
6. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
Evans G; Bryant HU; Magee D; Sato M; Turner RT
Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
Cui L; Wu T; Liu YY; Deng YF; Ai CM; Chen HQ
Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
[TBL] [Abstract][Full Text] [Related]
8. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
Kidder LS; Schmidt IU; Evans GL; Turner RT
Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
[TBL] [Abstract][Full Text] [Related]
10. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
[TBL] [Abstract][Full Text] [Related]
11. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
[TBL] [Abstract][Full Text] [Related]
12. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
Kangas L; Härkönen P; Väänänen K; Peng Z
Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
[TBL] [Abstract][Full Text] [Related]
13. Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats.
Nuttall ME; Bradbeer JN; Stroup GB; Nadeau DP; Hoffman SJ; Zhao H; Rehm S; Gowen M
Endocrinology; 1998 Dec; 139(12):5224-34. PubMed ID: 9832463
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats.
Turner RT; Wakley GK; Hannon KS; Bell NH
J Bone Miner Res; 1987 Oct; 2(5):449-56. PubMed ID: 3455628
[TBL] [Abstract][Full Text] [Related]
15. Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats.
Coxam V; Bowman BM; Mecham M; Roth CM; Miller MA; Miller SC
Bone; 1996 Aug; 19(2):107-14. PubMed ID: 8853853
[TBL] [Abstract][Full Text] [Related]
16. The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats.
Gallagher A; Chambers TJ; Tobias JH
Endocrinology; 1993 Dec; 133(6):2787-91. PubMed ID: 8243306
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
[TBL] [Abstract][Full Text] [Related]
18. Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.
Sibonga JD; Lotinun S; Evans GL; Pribluda VS; Green SJ; Turner RT
Endocrinology; 2003 Mar; 144(3):785-92. PubMed ID: 12586754
[TBL] [Abstract][Full Text] [Related]
19. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
[TBL] [Abstract][Full Text] [Related]
20. Specific bone-protective effects of metabolites/derivatives of tamoxifen and clomiphene in ovariectomized rats.
Ruenitz PC; Shen Y; Li M; Liang H; Whitehead RD; Pun S; Wronski TJ
Bone; 1998 Dec; 23(6):537-42. PubMed ID: 9855462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
